Libor webinar playback: spotlight on sterling

Panellists from Barclays, HSBC, Intralinks and Morgan Stanley discuss pros and cons of early cessation announcement


  • Doug Laurie, Libor transition programme lead for wholesale lending, corporate banking and private banking, Barclays
  • Maria Nogueiras, global head of collateral risk analytics, HSBC
  • Heidi Harrison, principal sales engineer, Intralinks
  • Ivan Jossang, managing director and global head of Libor transition for fixed income, Morgan Stanley
  • Duncan Wood, editorial director,

The next 12 months will determine how rates markets cope with the death of Libor.

With transition efforts now entering a critical phase,’s editorial team is running a series of quarterly webinars, breaking down the issues facing the market, tracking the progress made and highlighting the remaining questions. 

This quarter’s webinars kicked off on September 22 with a session focusing on the sterling market. Subscribers can replay the webinar above.

The discussion explores the pros and cons of an early notice of Libor cessation – and also considers its possible scope. Polled on the same questions, the audience expressed a strong preference for the date of Libor’s cessation to be confirmed before the middle of next year, but was divided on how broad the cessation should be. As things stand, there is no clarity on which of Libor’s 35 currency and tenor pairings will be discontinued, and there was some scepticism that the US market would be ready for US dollar Libor to die at the end of next year.

Towards the end of the debate, the discussion turns briefly to the question of when Isda’s fallback protocol will be adopted – and how widely – and also considers the industry’s call for regulatory relief on certain rules relating to traded risk models.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here